Prostate Protect
Prostate Protect, licence 80077286: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Complete Prostate Formula for Men, Health First - Prostate Protect
- Licence holder
- Accurex Health Care Manufacturing Inc.
- NPN or DIN-HM
- 80077286
- Status
- Active licence
- Licence date
- 8 May 2017
- Revision date
- 16 May 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vaccinium macrocarpon Source : Fruit | 250.0 mg | Not calculated |
| Lycopène tout trans Source : Solanum lycopersicum - fruit | 3.25 mg | Not calculated |
| Serenoa repens Source : Fruit Potency : 85.0 % Fatty acids | 50.0 mg | Not calculated |
| Cucurbita pepo Source : Graine(s) Extraction ratio : 20:1 Dry plant equivalent : 1500 mg | 75.0 mg | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 80.0 % combined beta-Sitosterol, Campesterol, Stigmasterol | 100.0 mg | Not calculated |
| Urtica dioica Source : Racine Extraction ratio : 22:1 Dry plant equivalent : 110 mg | 5.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 200.0 UI | 5.0 mcg | 10 µg |
Non-medicinal ingredients
Microcrystalline cellulose, Stéarate de magnésium, Poudre de caroube, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Helps to support prostate health. Provides antioxidants for the maintenance of good health. Source of an antioxidant that helps protect against oxidative stress. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80077286
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.